-
Entire Site
Products
Part Numbers
Applications
Technical Documents
Entire Site
Products
Part Numbers
Applications
Technical Documents
Publish Date | Press Release |
---|---|
08/23/2021 | Phenomenex Introduces New Biozen dSEC LC Columns |
06/17/2021 | Phenomenex Introduces NEW SINGLE GC Solution for Dioxin Analysis |
04/05/2021 | Phenomenex Announces Direct Sales and Support within Indonesia |
03/08/2021 | Phenomenex Expands Novum Product Line with Novum PRO SLE |
02/22/2021 | NEW bioZen Nano LC Columns |
Torrance, Calif. (April 25, 2016) – Phenomenex has added even more separation power to its novel UHPLC product portfolio with the introduction of the Luna Omega 1.6 µm Polar C18 stationary phase.
The Luna Omega Polar C18 is a novel UHPLC stationary phase capable of providing a unique selectivity within a wide elution window and increased retention for both polar and non-polar analytes. The all-purpose C18 ligand provides hydrophobic interactions while a polar modified particle surface delivers enhanced polar retention and aqueous stability. The ability to get combined retention of polars and non-polars by the Luna Omega Polar C18 means that this column has a very wide applicability and can be used in nearly every industry that depends on UHPLC instrumentation, including those that work with large compound screens, metabolite/impurity profiles, and even unknown natural products.
Compared to traditional alkyl phases, the Luna Omega Polar C18 offers greater polar compound retention. This can broaden the solvent systems at a chromatographer’s disposal for method development while also helping to deliver desired resolution between important compounds or even move peaks out of matrix suppression zones to allow for greater sensitivity. Unlike traditional C18 stationary phases, the polar modified surface of the Luna Omega Polar C18 gives it stability in 100 percent aqueous mobile phase conditions. This is useful for methods that may require resolution of problematic polar (acidic or basic) compounds that have poor retention under reversed phase conditions.
The Luna Omega Polar C18 can also be used to upgrade existing UHPLC methods. With a novel and finely tuned manufacturing process, Luna Omega 1.6 µm UHPLC silica is produced at the highest quality and consistency to ensure high efficiency, surface area, mechanical strength, and inertness. These attributes in combination with industry-leading packing technologies and a unique selectivity profile will potentially allow customers to realize lower limits of detection with increases in sensitivity levels as well as efficiency/peak capacity gains that aid in the resolution of closely eluting peaks. Combining the Polar C18 with the previously released fully porous Luna Omega C18 and Kinetex 1.7 µm core-shell phases further expands the options for UHPLC method development and improvement.
Enhanced with 20 years of technology, innovation, and experience, Luna Omega 1.6 µm columns build upon the Luna legacy to provide incredible UHPLC performance and selectivity. Now, with the addition of the Luna Omega Polar C18 stationary phase, the benefits of greater polar retention and 100 percent aqueous stability are also easily within reach.Find more information on the new Luna Omega 1.6 µm Polar C18 and C18 at: www.phenomenex.com/luna
Contact: Phenomenex Press Room
Tel: (310) 212-0555
Email: pressroom@phenomenex.com
Publish Date | Publication | Article Title |
---|---|---|
12/13/2019 | Cannabis testing: The need for robust methods and true transparency | |
05/08/2019 | Rapid Extraction and Analysis of PPCPs From Sediments |
Publish Date | Publication | Article Title |
---|---|---|
11/14/2018 | Chromatographic Analysis for PAT | |
11/12/2018 | High-Flow Weak Cation Exchange for Charge Variant Analysis | |
06/01/2018 | Bio-Inert versus Bio-Compatible: The Benefits of Different Column Materials in Liquid Chromatography... | |
02/23/2018 | Meeting the Demands of the Food Safety Laboratory Using Versatile Columns |
Publish Date | Publication | Article Title |
---|---|---|
07/18/2017 | SelectScience Interview: Improving Food Safety at the United States Department of Agriculture | |
06/20/2017 | Addressing the Challenges of Drug-to-Antibody Measurement | |
02/24/2017 | Dietary Supplements Method Modernization- A Review of Current Efforts to Modetnize Compendial Method... | |
02/14/2017 | How to Optimize Your Reversed Phase Chromatography |
Publish Date | Publication | Article Title |
---|---|---|
12/14/2016 | Customized Separation Solutions from PhenoLogix Experts | |
11/02/2016 | The Secrets Behind the Success of Phenomenex- Tips to the Top | |
10/06/2016 | The Phenomenex Story Part II: Leading the Field in Urine Analysis | |
09/27/2016 | Urinary Drug Testing: Small Changes for Big Improvements in Sensitivity | |
09/22/2016 | The Phenomenex Story Part I: The Architect Who Build a Chemistry Empire | |
07/6/2016 | Urine Analytics: The Good, The Bad, and The Ugly | |
07/20/2016 | Approaches to prescription opioid abuse testing |
Publish Date | Publication | Article Title |
---|---|---|
12/10/2015 | Allowable Adjustments to Pharmacopoeia Methods for Isocratic and Gradient Separations | |
10/1/2015 | New Approaches to Screening for Drug Abuse | |
04/09/2015 | Torrance Tribune - Crushing Malaria | |
03/03/2015 | Identifying the Increased Scope of Core-Shell Technology for HPLC and UHPLC Chromatographers |
Publish Date | Publication | Article Title |
---|---|---|
12/02/2014 | Eliminating Volumetric Haematocrit Bias Associated with DBS Sub-Punch Workflows Using a Novel Micros... |